As of 2025-09-18, the Relative Valuation of Revance Therapeutics Inc (RVNC) is (33.83) USD. This relative valuation is based on P/E multiples. With the latest stock price at 3.65 USD, the upside of Revance Therapeutics Inc based on Relative Valuation is -1027.0%.
The range of the Relative Valuation is (32.09) - (34.35) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 16.2x - 19.4x | 18.7x |
| Forward P/E multiples | 18.2x - 21.0x | 19.6x |
| Fair Price | (32.09) - (34.35) | (33.83) |
| Upside | -979.1% - -1041.0% | -1027.0% |
| Date | P/E |